机构：[1]Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC[2]School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan[3]Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Pok Fu Lam, Hong Kong[4]School of Pharmacy, Monash University Malaysia, Selangor, Malaysia[5]Center for Pharmaceutical Outcomes Research, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand[6]School of Pharmacy, University of Wisconsin, Madison, WI[7]School of Population Health, University of Queensland, Brisbane, QLD, Australia[8]Graduate Institute of Clinical Medicine Science, China Medical University, Taichung, Taiwan[9]Department of Pharmacoepidemiology, University of Tokyo, Tokyo, Japan[10]Department of Epidemiology, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore, Singapore[11]Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea[12]Office of Drug Utilization Review, Korea Institute of Drug Safety and Risk Management, Seoul, South Korea[13]Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute for Health Research, University of South Australia, Adelaide, SA, Australia[14]Pharmacy Practice, Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani, Thailand[15]Institute of Hospital Management, West China Hospital, Sichuan University, Sichuan, People's Republic of China.四川大学华西医院
This study describes the availability and characteristics of databases in Asian-Pacific countries and assesses the feasibility of a distributed network approach in the region.
A web-based survey was conducted among investigators using healthcare databases in the Asia-Pacific countries. Potential survey participants were identified through the Asian Pharmacoepidemiology Network.
Investigators from a total of 11 databases participated in the survey. Database sources included four nationwide claims databases from Japan, South Korea, and Taiwan; two nationwide electronic health records from Hong Kong and Singapore; a regional electronic health record from western China; two electronic health records from Thailand; and cancer and stroke registries from Taiwan.
We identified 11 databases with capabilities for distributed network approaches. Many country-specific coding systems and terminologies have been already converted to international coding systems. The harmonization of health expenditure data is a major obstacle for future investigations attempting to evaluate issues related to medical costs.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2015]版：
大类|2 区医学
小类|1 区公共卫生、环境卫生与职业卫生
最新[2025]版：
大类|2 区医学
小类|2 区公共卫生、环境卫生与职业卫生
第一作者：
第一作者机构：[1]Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC[2]School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan
通讯作者：
通讯机构：[1]Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC[*1]Duke Clinical Research Institute, Duke University School of Medicine, P.O. Box 17969, Durham, NC 27715
推荐引用方式(GB/T 7714)：
Lai Edward Chia-Cheng,Man Kenneth K C,Chaiyakunapruk Nathorn,et al.Brief Report: Databases in the Asia-Pacific Region: The Potential for a Distributed Network Approach.[J].Epidemiology (Cambridge, Mass.).2015,26(6):815-20.doi:10.1097/EDE.0000000000000325.
APA：
Lai Edward Chia-Cheng,Man Kenneth K C,Chaiyakunapruk Nathorn,Cheng Ching-Lan,Chien Hsu-Chih...&Setoguchi Soko.(2015).Brief Report: Databases in the Asia-Pacific Region: The Potential for a Distributed Network Approach..Epidemiology (Cambridge, Mass.),26,(6)
MLA：
Lai Edward Chia-Cheng,et al."Brief Report: Databases in the Asia-Pacific Region: The Potential for a Distributed Network Approach.".Epidemiology (Cambridge, Mass.) 26..6(2015):815-20
